Anti-IL-36R antibodies, potentially useful for the treatment of psoriasis: a patent evaluation of WO2013074569

By Wolf Joel   Ferris Laura Korb  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 477-479

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic compounds: patent evaluation of WO2011011652A1

By Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1491-1495

Informa Healthcare

Access to resources Recommend Favorite

Novel antibody to a carbonic anhydrase: patent evaluation of WO2011138279A1

By Winum Jean-Yves  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 6, 2013-06 ,pp. : 757-760

Informa Healthcare

Access to resources Recommend Favorite

Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1

By Chiurchiù Valerio   Maccarrone Mauro   Orlacchio Antonio  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 2, 2012-02 ,pp. : 181-184

Informa Healthcare

Access to resources Recommend Favorite

N-aryl pyrazoles, indazoles and azaindazoles as antagonists of CC chemokine receptor 1: patent cooperation treaty applications WO2010/036632, WO2009/134666 and WO2009/137338

By Carter Percy H   Hynes John  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. : 1609-1618

Informa Healthcare

Access to resources Recommend Favorite